K-924 LD

DRUG2 trials

Sponsors

Kowa Company, Ltd.

Conditions

Hypercholesterolemia

Phase 3

K-924 Phase III Confirmatory Study

CompletedNCT04289649

Kowa Company, Ltd.Hypercholesterolemia

Start: 2020-04-02End: 2020-11-21Updated: 2023-11-29

K-924 Phase III Long Term Study

CompletedNCT04289662

Kowa Company, Ltd.Hypercholesterolemia

Start: 2020-03-23End: 2021-08-07Updated: 2023-11-29

Related Papers

Efficacy and Safety of Pitavastatin/Ezetimibe Fixed-Dose Combination vs. Pitavastatin: Phase III, Double-Blind, Randomized Controlled Trial

Journal of Atherosclerosis and Thrombosis2023-03-108 citations